Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -154,432 | -96,974 | -45,995 | -163,918 | -118,927 |
| Depreciation Amortization | -1,851 | -878 | -247 | 1,017 | 1,088 |
| Other Working Capital | -257 | -5,111 | -687 | 18,612 | 16,244 |
| Other Operating Activity | 28,748 | 16,510 | 6,211 | 29,084 | 21,597 |
| Operating Cash Flow | $-127,792 | $-86,453 | $-40,718 | $-115,205 | $-79,998 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -109,352 | 80,444 | 48,771 | -172,324 | -209,451 |
| PPE Investments | -3,753 | -253 | -16 | -1,656 | -1,382 |
| Investing Cash Flow | $-113,105 | $80,191 | $48,755 | $-173,980 | $-210,833 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 351,019 | 13,142 | 484 | 121,963 | 121,848 |
| Financing Cash Flow | $351,019 | $13,142 | $484 | $121,963 | $121,848 |
| Beginning Cash Position | 33,973 | 33,973 | 33,973 | 201,195 | 201,195 |
| End Cash Position | 144,095 | 40,853 | 42,494 | 33,973 | 32,212 |
| Net Cash Flow | $110,122 | $6,880 | $8,521 | $-167,222 | $-168,983 |
| Free Cash Flow | |||||
| Operating Cash Flow | -127,792 | -86,453 | -40,718 | -115,205 | -79,998 |
| Capital Expenditure | -3,753 | -253 | -16 | -1,656 | -1,382 |
| Free Cash Flow | -131,545 | -86,706 | -40,734 | -116,861 | -81,380 |